Bio Techne Corp (TECH):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Bio Techne Corp (TECH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10115)・商品コード:DATA904C10115
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:62
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoassays, biologically active chemical compounds, and in situ genomic hybridization. It offers Western blot, enzyme-linked immunosorbent assay, and biologics platform. Bio Techne also offers controls and calibrators for hematology clinical instruments. Bio Techne’s products find application in scientific investigation of biological processes and also to identify the nature and progress of certain diseases. The company sells its products through an extensive network of distributors across the world. It caters to biotechnology research and clinical diagnostic markets. The company has subsidiaries in the UK, Canada, and China. Bio Techne is headquartered in Minneapolis, Minnesota, the US.

Bio Techne Corp (TECH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bio Techne Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bio Techne Corp, Medical Devices Deals, 2012 to YTD 2018 10
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bio Techne Corp, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Quad Technologies Raises Funds through Series A Financing 13
Zephyrus Biosciences Raises USD1.5 Million in Seed Financing 14
Partnerships 15
Exosome Diagnostics Enters into Agreement with Intezyne 15
Quad Technologies Enters into Partnership with Sartorius Stedim Biotech 16
COPD Foundation Enters into Agreement with Bio Techne 17
Quad Technologies Partners with University of Massachusetts Medical School 18
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 19
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 20
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 21
Licensing Agreements 22
Bio-Techne Enters into Licensing Agreement with MRC for Protein Synthesis Technology 22
Equity Offering 23
Astute Medical Raises USD43 Million in Private Palcement of Shares 23
ProteinSimple Withdraws IPO 24
ChemoCentryx Completes Private Placement Of Shares For US$5 Million 25
Acquisition 26
Bio-Techne to Acquire Quad Technologies 26
Bio Techne Acquires Atlanta Biological 27
Bio Techne Acquires Trevigen 28
Bio-Techne Acquires Zephyrus Biosciences 29
Bio-Techne Acquires Cyvek 30
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 31
Bio-Techne Acquires Novus Biologicals for USD60 Million 33
Bio-Techne Acquires Shanghai PrimeGene Bio-Tech 34
Novus Biologicals Acquires Imgenex, Biotech Company 35
Bio Techne Corp – Key Competitors 36
Bio Techne Corp – Key Employees 37
Bio Techne Corp – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 40
Financial Announcements 40
Oct 30, 2018: Bio-Techne releases first quarter fiscal 2019 results 40
Aug 07, 2018: Bio-Techne releases fourth quarter fiscal 2018 results 43
May 02, 2018: Bio-Techne Releases Third Quarter Fiscal 2018 Results 46
Feb 06, 2018: Bio-Techne Reports Net Sales Of $154.2 million In The Second Quarter Of Fiscal 2018 48
Oct 31, 2017: Bio-Techne Releases First Quarter Fiscal 2018 Results 50
Aug 08, 2017: Bio-Techne Releases Fourth Quarter Fiscal 2017 Results 52
Feb 07, 2017: Bio-Techne Releases Second Quarter Fiscal 2017 Results 55
Corporate Communications 57
Oct 26, 2017: Bio-Techne Adds Two New Directors to Its Board 57
Product News 58
Mar 14, 2018: Bio-Techne Launches MimEX GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract 58
Other Significant Developments 59
Jul 24, 2018: Bio-Techne introduces new member of the Simple Western Family, with IR/NIR detection capabilities 59
Jul 10, 2018: Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets 60
Apr 26, 2018: Bio-Techne Leads the Way in Scientific Support for Autophagy Research 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Bio Techne Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bio Techne Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bio Techne Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Bio Techne Corp, Medical Devices Deals, 2012 to YTD 2018 10
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Quad Technologies Raises Funds through Series A Financing 13
Zephyrus Biosciences Raises USD1.5 Million in Seed Financing 14
Exosome Diagnostics Enters into Agreement with Intezyne 15
Quad Technologies Enters into Partnership with Sartorius Stedim Biotech 16
COPD Foundation Enters into Agreement with Bio Techne 17
Quad Technologies Partners with University of Massachusetts Medical School 18
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 19
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 20
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 21
Bio-Techne Enters into Licensing Agreement with MRC for Protein Synthesis Technology 22
Astute Medical Raises USD43 Million in Private Palcement of Shares 23
ProteinSimple Withdraws IPO 24
ChemoCentryx Completes Private Placement Of Shares For US$5 Million 25
Bio-Techne to Acquire Quad Technologies 26
Bio Techne Acquires Atlanta Biological 27
Bio Techne Acquires Trevigen 28
Bio-Techne Acquires Zephyrus Biosciences 29
Bio-Techne Acquires Cyvek 30
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 31
Bio-Techne Acquires Novus Biologicals for USD60 Million 33
Bio-Techne Acquires Shanghai PrimeGene Bio-Tech 34
Novus Biologicals Acquires Imgenex, Biotech Company 35
Bio Techne Corp, Key Competitors 36
Bio Techne Corp, Key Employees 37
Bio Techne Corp, Subsidiaries 38

List of Figures
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Bio Techne Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Bio Techne Corp, Medical Devices Deals, 2012 to YTD 2018 10

★調査レポート[Bio Techne Corp (TECH):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C10115)販売に関する免責事項を必ずご確認ください。
★調査レポート[Bio Techne Corp (TECH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆